409

EFFECT OF RECTAL LOCATION ON POST-COLONOSCOPY COLORECTAL CANCER OUTCOMES

Date
May 19, 2024

Background and Aims: Post-Colonoscopy Colorectal Cancer (PCCRC) refers to CRC diagnosed after a colonoscopy in which no cancer was found. The rectum is the second most common location for PCCRC after the right colon. Rectal cancer has different biologic behavior than CRC located elsewhere in the colon, but whether a rectal location for PCCRC affects all-cause mortality (ACM) and colorectal cancer-specific mortality (CSM) differently than other locations is not known.
Methods: We performed a secondary analysis of a VA–Medicare administrative database that included all Veterans aged 50 to 85 years with newly diagnosed CRC between 1/1/2003 and 12/31/2013, examining prior exposure to colonoscopy. Patients whose colonoscopy occurred ≤ 6 months prior to CRC diagnosis with no other prior colonoscopy within the previous 36 months were categorized as Detected CRC (DCRC). Those whose colonoscopy occurred 6-36 months prior to CRC diagnosis were categorized as PCCRC-3y. Using Cox proportional hazards (with censoring, last follow-up 12/31/2018), we assessed ACM and CSM after a CRC diagnosis, stratified by location (rectum, right colon) and whether a PCCRC or DCRC.
Results: The analyses are summarized in the Table. There was no significant difference in CSM between rectal PCCRC-3y and rectal DCRC regardless of adjustment for stage (hazard ratios [HR] 1.11, 95% CI: 0.91-1.34 and 1.03 (0.85, 1.25), respectively). Compared with rectal DCRC, patients with rectal PCCRC-3y had comparable ACM, though this became marginally significantly higher after adjustment for stage (HR 1.15 (1.00-1.33), p=0.047). Among PCCRC-3y cases, rectal location was associated with significantly higher ACM (HR 1.35) and CSM (HRs 1.49-1.56) compared with right-sided location irrespective of adjustment for stage. Among DCRC cases, rectal location was also associated with significantly higher ACM (HRs 1.33-1.37) and CSM (HRs 1.56-1.67) than right-sided location irrespective of adjustment for stage.
Conclusions: Rectal cancer is associated with worse ACM and CSM than right-sided colon cancer, and does not appear to be influenced by stage or whether the cancer was classified as DCRC or PCCRC-3y. Additional studies in more contemporary cohorts are needed to confirm our findings, and explore underlying mechanisms.

Presenter

Speaker Image for Charles Kahi
Indiana University School of Medicine

Tracks

Related Products

Thumbnail for COLONOSCOPY ADHERENCE IN A MULTI-CENTER STUDY OF COLORECTAL CANCER (CRC) SCREENING
COLONOSCOPY ADHERENCE IN A MULTI-CENTER STUDY OF COLORECTAL CANCER (CRC) SCREENING
BACKGROUND: The Nordic-European Initiative on Colorectal Cancer (NordICC) Study highlighted the impact of adherence on the effectiveness of colonoscopy at reducing CRC incidence and mortality…
Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
Talks on the blood based screening test clinical trial results that will occur in 2022 and 2023 (ECLIPSE, PREEMPT, BLUE-C) and effects on clinical care; updates on multi-cancer early detection test; emerging screening tests (Oncoguard, Colonosight, etc)…
Thumbnail for Meet the Editors: How to Get Published in an AGA Journal
Meet the Editors: How to Get Published in an AGA Journal
SOCIETY: AGA Editors from AGA's portfolio of journals will present details about their specific journal, including best practices for authors and tips for what makes a successful submission. A substantial Q&A session will be available for attendees…